Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials-Reference-Cited by-同舟云学术

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

Published:2009-01-20 Issue:2 Volume:119 Page:351-357
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Skyler Jay S.¹,Bergenstal Richard¹,Bonow Robert O.¹,Buse John¹,Deedwania Prakash¹,Gale Edwin A.M.¹,Howard Barbara V.¹,Kirkman M. Sue¹,Kosiborod Mikhail¹,Reaven Peter¹,Sherwin Robert S.¹

Affiliation:

1. From the University of Miami, Miami, Fla (J.S.S.); International Diabetes Center at Park Nicollet, Minneapolis, Minn (R.B.); Northwestern University Feinberg School of Medicine, Chicago, Ill (R.O.B.); University of North Carolina, Chapel Hill (J.B.); VA Central California Healthcare System, University of California San Francisco, Fresno (P.D.); University of Bristol, Bristol, UK (E.A.M.G., B.V.H.); MedStar Research Institute, Hyattsville, Md (B.V.H.); American Diabetes Association, Alexandria, Va (M...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.108.191305

Reference16 articles.

1. The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes Mellitus

2. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

3. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

4. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

Cited by 302 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese medicine Linggui Zhugan formula protects against diabetic kidney disease in close association with inhibition of proteinase 3-mediated podocyte apoptosis in mice;Journal of Ethnopharmacology;2024-12

2. Dapagliflozin attenuates AKI to CKD transition in diabetes by activating SIRT3/PGC1-α signaling and alleviating aberrant metabolic reprogramming;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

3. Significance of Myocardial Perfusion SPECT (Single-Photon Emission Computed Tomography) Imaging in the Detection of Silent Myocardial Ischemia in Type II Diabetic Patients with Microalbuminuria;Pakistan BioMedical Journal;2024-08-31

4. Basal Insulin Initiation in Adults With Type 2 Diabetes Mellitus: A Retrospective Cohort Study Using Administrative Health Data in Alberta, Canada;Canadian Journal of Diabetes;2024-08

5. Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study;Diabetes Care;2024-03-14